G protein and cAMP-dependent protein kinase mediate amyloid β-peptide inhibition of neuronal glucose uptake

Experimental Neurology

Volumn 167, Issue 1, 2001, Pages 59-64

  Prapong, Teerasak ^a   Uemura, Etsuro ^a   Hsu, Walter H ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; cAMP; G protein; Glucose uptake; Hippocampal neuron; amyloid

Indexed keywords

ADENYLATE CYCLASE; AMYLOID BETA PROTEIN; BUCLADESINE; CHOLERA TOXIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; GLUCOSE; GUANINE NUCLEOTIDE BINDING PROTEIN; KT 5720;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL LEVEL; CELL METABOLISM; CONTROLLED STUDY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HIPPOCAMPUS; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TISSUE CULTURE;

EID: 0035152374     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7519     Document Type: Article

References (40)

1. 2+-dependent late phase
2. Inpaired G-protein-stimulated adenylyl cyclase activity in Alzheimer's disease brain is not accompanied by reduced cyclic-AMP-dependent protein kinase A activity
3. Adenylyl cyclase activity in postmortem human brain: Evidence of altered G protein mediation in Alzheimer's disease
4. Positron emission tomography in Alzheimer's disease
5. ATP and brain functon
6. Disturbances in signal transduction mechanisms in Alzheimer's disease
7. G proteins: Transducers of receptor-generated signals
8. Characteristics of glucose transport in neuronal cells and astrocytes from rat brain in primary culture
9. Functional alterations in Alzheimer's disease: Decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone
10. Oxidative energy metabolism in Alzheimer brain: Studies in early-onset and late onset cases
11. Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: A cross-sectional comparison against advanced late-onset and incipient early-onset cases
12. Diminished glucose transport in Alzheimer's disease: Dynamic: PET studies
13. Isoproterenol stimulates phosphorylation of the insulin-regulatable glucose transporter in rat adipocytes
14. Amyloid β-peptide impairs glucose and glutamate transport, induces oxidative stress in mitochondria, and reduces ATP levels in synaptosomes: Role of the lipid peroxidation product 4-hydroxynonenal
15. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease
16. High-resolution PET studies in Alzheimer's disease
17. Phosphorylation of the glucose transporter in rat adipocytes
18. GLUT4 facilitates insulin stimulation and cAMP-mediated inhibition of glucose transport
19. Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons: Involvement of membrane lipid peroxidation
20. Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives
21. Robustness of G proteins in Alzheimer's disease: An immunoblot study
22. Neurochemical enzyme changes in Alzheimer's and Pick's disease
23. Adenylate cyclases: Critical foci in neuronal signaling
24. G protein antagonists
25. The inhibitory effects of β-amyloid on glutamate and glucose uptakes by cultured astrocytes
26. Alterations of cerebral metabolism in probable Alzheimer's disease
27. GLUT4 phosphorylation and inhibition of glucose transport by dibutyryl cAMP
28. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E
29. Cognitive and brain imaging measures of Alzheimer's disease
30. Alterations in the activity of adenylate cyclase and high affinity GTPase in Alzheimer's disease
31. Signal sorting and amplification through G protein-coupled receptors
32. Increased in vitro phosphorylation of a Mr 60,000 protein in brain from patients with Alzheimer's disease
33. Adenylyl cyclase activity in Alzheimer's disease brain: Stimulatory and inhibitory signal transduction pathways are differently affected
34. Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brain of patients with Alzheimer's disease
35. 2+/calmodulin-dependent protein Kinase II
36. Glucose-dependent regulation of glucose transport activity, protein, and mRNA in primary cultures of rat brain glial cells
37. Receptor-mediated activation of G protein is reduced in postmortem brains from Alzheimer's disease patients
38. Mechanisms of neuronal degeneration in Alzheimer's disease